UAG
GILD icon

United Advisor Group’s Gilead Sciences GILD Stock Holding History

United Advisor Group’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-1,559
Closed -$217K – 560
2026
Q1 		$217K Buy
+1,559
New +$218K 0.03% 472
2025
Q2 		– Sell
-3,892
Closed -$436K – 389
2025
Q1 		$436K Buy
+3,892
New +$402K 0.09% 207

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

United Advisor Group's GILD Position: Q2 2026 in Review

United Advisor Group sold out of Gilead Sciences (GILD) in Q2 2026, closing a stake of 1,559 shares — an estimated $217K sold.

United Advisor Group first reported a position in GILD in Q1 2025 and held it in 2 quarters. The position peaked at $436K in Q1 2025. 2,283 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • United Advisor Group reported no remaining Gilead Sciences position as of Q2 2026 after selling out during the quarter.
  • United Advisor Group sold 1,559 Gilead Sciences shares in Q2 2026, an estimated $217K.
  • United Advisor Group first reported a position in Gilead Sciences in Q1 2025 and held it in 2 quarters.
  • United Advisor Group's Gilead Sciences position peaked at $436K in Q1 2025.
  • 2,283 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on United Advisor Group's 13F filing for Q2 2026, filed 29 Jul 2026.